What Makes or Breaks a Clinical Trial Event with Alex O’Leary

In this episode, Maya meets Colin Sholes. Colin is the founder of Cure Clinical Inc., a US-based software company building a comprehensive database for clinical research performance analysis.

Maya and discuss the following topics:

(4:29) Why is a direct-to-consumer business similar to patient recruitment

(8:06) How to balance the pitch to patients with the site demands

(11:23) How to achieve consistency in patient recruitment ads

(14:40) Are sponsors and CROs reacting to clinical sites direct feedback

(16:58) How does Cure Clinical make trials more scalable

(20:50) Do sites need better statistics or better tools

(24:00) The #1 solution to make trials more patient-friendly

Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge! 

Maya Zlatanova, CEO of Trialhub

Colin Sholes, Founder of Cure Clinical

See More:

TrialHub

Cure Clinical

In this episode, Maya meets David Rosenbaum to talk about immigrants in clinical trials. David helps scatter the immigrant bias with clinical trials in Turkey and other Balkan countries. However, it’s an ongoing administrative effort. 

David is the Founder of Rosenbaum Group. It is a CRO operating since 2019 in the south-eastern Balkans and Turkey. The organization focuses on clinical trials in CNS, infectious diseases, and gastroenterology. It also supports BIOTECH research and medical devices with a patient-centric approach.

Maya and David discuss the following topics:

(2:30) Immigrant story from a clinical trial in Turkey

(7:12) What makes immigrants vulnerable patients

(9:50) The situation with immigrants and trials in the Balkans

(12:48) Ways to improve communication with authorities

(16:06) Tech portals vs direct communication with regulatory bodies

(19:40) What can ethics committees improve further

(23:02) The #1 thing to make trial patient-friendly

Tune in today for a thrilling journey into clinical trials – expand your knowledge! 

Maya Zlatanova, CEO of Trialhub

David Rosenbaum, Clinical Trial Manager @ Rosenbaum Group Ltd. 

See More:

TrialHub

Rosenbaum Group Ltd. 

In this episode, Maya meets Dr. Leeza Osipenko. She is the founder and the CEO of a non-profit organization Consilium Scientific. It is dedicated to improving the integrity of clinical research.

Maya and Leeza discuss the following topics:

(2:18) The role of NICE in developing clinical standards

(6:23) Why did Leeza start Consilium Scientific

(9:35) How to avoid suboptimal clinical trials

(19:02) What are the mechanisms that improve clinical research integrity

(25:30) The ultimate goal of Consilium Scientific

(32:47) What is the biggest challenge in clinical trials at the moment

Tune in today for a thrilling journey into the world of clinical research – expand your knowledge! 

Maya Zlatanova, CEO of Trialhub

Leeza Osipenko, CEO of Consilium Scientific 

See More:

TrialHub

Consilium Scientific

In this episode, Maya meets Andreas, who is a part of the new generation of CRO leaders. He has new ideas and concepts of how to bring better clinical research services to the market and make trials more accessible.

Maya and Andreas discuss the following topics:

(2:55) Why aren’t more students pursuing careers in clinical trials?

(6:35) What does the Association of International CROs do?

(10:49) How to balance global trial coverage with local support?

(8:32) Should big companies manage local teams as mini-companies?

(18:38) How to face clinical trial challenges as an international company?

(24:43) What’s the future of clinical research organizations?

Tune in today to catch the latest insights and emerging trends in the world of clinical trials. 

Maya Zlatanova, CEO of TrialHub

Andreas Beust, CEO of GCP-Service International and

President of AICROS

See More:

TrialHub

GCP-Service International 

AICROS

In this episode, Maya meets Till, the founder of TranspariMED. Till is a political scientist by background, now focused on raising awareness about clinical trial transparency. 

Maya and Till discuss the following topics:

(1:19) How to achieve transparency in clinical trials

(3:37) Should all trials be fully transparent

(5:26) The current state of clinical trial transparency

(8:32) Who should enforce reporting clinical trial results

(14:58) Who benefits from opacity in clinical trial results

(20:35) How to foster better transparency in trials

(29:54) What makes or breaks clinical trials

Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge! 

Maya Zlatanova, CEO of Trialhub

Till Bruckner, Founder of TranspariMED

See More:

TrialHub

TranspariMED

In this episode, Maya meets Steve. Steve is the VP of partnerships for 1nHealth. He brings a wide-ranging scope of experience to his role, having worked previously in digital marketing, e-commerce, and education. He is primarily responsible for assessing digital recruitment feasibility and developing external partnerships.

Maya and Steve discuss the following topics:

(2:00) The common things between patient recruitment and e-commerce

(4:48) The 3 e-commerce tactics that can be applied to patient recruitment

(11:57) Are iterations of patient recruitment ads expensive

(13:53) The #1 platform for patient recruitment 

(19:59) Real-life stories from patient recruitment campaigns

(27:48) What makes or breaks clinical trials

Tune in today and start expanding your knowledge!

Maya Zlatanova, CEO of Trialhub

Steve Wimmer, VP of Partnerships for 1nHealth

See More:

TrialHub

1nHealth

In this episode, Maya and Raymond discuss the following topics:

(2:09) What’s happening right now with clinical sites

(5:23) Should sites choose their own tech stack

(8:24) How to build better ePRO workflows

(13:06) The 1 way to offer global solutions for sites

(16:09) What is the future of sites

(23:09) How can clinical trials get more collaborative 

Tune in today and start expanding your knowledge!

Maya Zlatanova, CEO of Trialhub

Raymond Nomizu, Co-Founder of CRIO

See More:

TrialHub

CRIO

In this episode, Maya sits with Carole Scrafton, Director and Co-Founder of a Patient Advocacy Organisation. They deep dive into the following topics:

(4:00) How has access to clinical trials altered?

(8:36) Do companies approach patients for clinical trials?

(11:47) How to assess proposals from small companies?

(16:13) Who should be more proactive: doctors or patients?

(19:55) Carole’s first experience with a clinical trial

(24:35) How to accelerate change in clinical trials?

Tune in today and start expanding your knowledge!

Maya Zlatanova, CEO of Trialhub

Carole Scrafton, Director & Co-Founder of Flutters and Strutters

See More:

TrialHub

Flutters and Strutters

 In this episode, Maya and Kimberly, Founder and CEO of ESPERO, discuss the following topics:

(2:20) What does a Head of Digital Clinical Trials do?

(4:36) How can we speed up clinical trials?

(7:54) Top inefficient trial processes requiring a shift

(12:00) The main challenge in clinical trials

(15:38) Bridging the gap between companies and patients

(20:00) How to improve protocol design

(23:51) Why the industry is still not ready for AI and ML

Tune in today and start expanding your knowledge!

Maya Zlatanova, CEO of Trialhub

Kimberly Tableman, CEO of ESPERO

See More:

TrialHub

ESPERO

In this episode, Maya and Duncan, president of DTS Language Services, shed light on translations involved in clinical trials. They discuss the following topics:

(2:09) The mission and purpose behind informed consent

(4:35) How to apply D&I to the informed consent 

(6:45) What problems arise in translating consent forms

(10:37) AI and translations in clinical trials

(12:47) Best practices in clinical research and translations

(15:54) Duncan’s experience from working with sponsors

(21:21) What makes or breaks a clinical trial

Tune in today and start expanding your knowledge!

Maya Zlatanova, CEO of Trialhub

Duncan Shaw, President at DTS Language Services

See More:

TrialHub

DTS Language Services